Beauchemin v. Persons Plastic Surgery CA1/4

CourtCalifornia Court of Appeal
DecidedOctober 27, 2025
DocketA170578
StatusUnpublished

This text of Beauchemin v. Persons Plastic Surgery CA1/4 (Beauchemin v. Persons Plastic Surgery CA1/4) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Beauchemin v. Persons Plastic Surgery CA1/4, (Cal. Ct. App. 2025).

Opinion

Filed 10/27/25 Beauchemin v. Persons Plastic Surgery CA1/4

NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

IN THE COURT OF APPEAL OF THE STATE OF CALIFORNIA

FIRST APPELLATE DISTRICT

DIVISION FOUR

ERIN BEAUCHEMIN et al., Plaintiffs and Appellants, A170578 v. (Contra Costa County PERSONS PLASTIC SURGERY et Super. Ct. No. C2102629) al., Defendants and Respondents.

In this medical malpractice case, plaintiffs Erin Beauchemin and Ethan Locks (collectively, plaintiffs) appeal after the trial court granted summary judgment in favor of defendants Dr. Barbara Persons and her practice, Persons Plastic Surgery (collectively, defendants). Plaintiffs contend Dr. Persons negligently performed a breast augmentation procedure on Ms. Beauchemin, specifically by placing the implants improperly, causing Ms. Beauchemin to suffer severe pain. Mr. Locks, who is Ms. Beauchemin’s husband, asserts a cause of action for loss of consortium (a claim that the parties agree “rises and falls” with Ms. Beauchemin’s professional negligence claim). In granting summary judgment, the trial court determined first that an expert declaration submitted by defendants met their initial burden of

1 production as to the breach and causation elements of plaintiffs’ medical negligence claim, thus shifting to plaintiffs the burden to produce evidence creating triable issues of fact as to those elements. Plaintiffs did not submit an expert declaration in response, relying instead on their own declarations, in which they recounted out-of-court statements by a later treating physician. The trial court sustained hearsay objections to those portions of plaintiffs’ declarations and concluded plaintiffs did not show triable issues of fact existed as to the breach and causation elements of the medical negligence claim. On appeal, plaintiffs contend defendants did not meet their initial burden of production, because the declaration of the defense medical expert contained unsupported opinions that should have been excluded. Plaintiffs further argue that, even if defendants met their initial burden, summary judgment was improper because the out-of-court statements on which plaintiffs rely are admissible and establish the existence of triable issues of fact.1 We affirm. I. BACKGROUND A. Ms. Beauchemin’s Medical Treatment On September 21, 2020, Ms. Beauchemin had a breast augmentation procedure, which Dr. Persons performed. Dr. Persons placed “650cc silicone filled smooth round high profile Sientra implants.” As summarized by the

1 In their opening appellate brief, plaintiffs also asserted that,

regardless of whether triable issues of fact exist as to the breach and causation elements of their medical negligence claim, summary judgment was improper because there are triable issues pertaining to plaintiffs’ theory that Dr. Persons was negligent in failing to obtain Ms. Beauchemin’s informed consent for the breast augmentation procedure. In their reply brief, plaintiffs state they are withdrawing that argument from this court’s consideration on appeal.

2 trial court, the placement of the implants was “subglandular and subfascial— under the glands and above the muscle and under the fascia to allow the nipple to be elevated slightly.” In an “operative report” describing the procedure, Dr. Persons stated the implants were “confirmed to be symmetrical and in proper position.” There were no complications. Liposuction was also performed on Ms. Beauchemin’s “anterior axillary creases (bra rolls).” At follow-up appointments in late September and early October, Ms. Beauchemin reported she was experiencing “continuous” pain and asked for more pain medication. Later, in her deposition, Ms. Beauchemin described the pain as “excruciating.” The pain was concentrated in Ms. Beauchemin’s left breast. In her visit notes, Dr. Persons stated Ms. Beauchemin’s pain was out of proportion to the physical findings. Bruising was mostly resolved; the incision was clean, dry, and intact; and there was some swelling. At an appointment on October 5, 2020, Dr. Persons prescribed more pain medication but explained it would be the last prescription due to Ms. Beauchemin’s controlled substance prescriptions on her CURES2 history. On October 8, 2020, Dr. Persons performed an exploration of Ms. Beauchemin’s left anterior axillary crease (an area where liposuction was performed during the previous procedure, and the area where Ms. Beauchemin reported pain). Dr. Persons’ notes state “[n]o significant abnormality” was found. Dr. Persons removed a small area of firm fat. On January 16, 2021, Ms. Beauchemin returned for another appointment at which she complained of continued left breast pain in the upper lateral quadrant. Dr. Persons suggested that Ms. Beauchemin get an ultrasound and mammogram of the area, but Ms. Beauchemin was reluctant

2 Controlled Substance Utilization Review and Evaluation System.

3 to do so. Although no abnormalities were noted, Dr. Persons offered to explore the implant pocket and left upper quadrant to evaluate for neuroma. Dr. Persons stated in her notes that Ms. Beauchemin was exhibiting drug- seeking behavior, and that she would not prescribe further medications. Ms. Beauchemin was also interested in minor leg liposuction. On January 21, 2021, Ms. Beauchemin had another procedure with Dr. Persons for liposuction of her thighs and knees and exploration of the left breast. Dr. Persons’ notes state the implant was in the correct position. On January 26, 2021, Ms. Beauchemin had a follow-up appointment at which it was noted that her incisions were doing well and that any narcotics would be prescribed by a pain doctor. On August 11, 2021, Ms. Beauchemin returned to Dr. Persons with complaints of left breast upper quadrant pain. The assessment was to send Ms. Beauchemin for a mammogram and ultrasound as previously recommended. Ms. Beauchemin did not want to pay out of pocket, so Dr. Persons offered a referral for the imaging. On August 24, 2021, Dr. Persons offered and recommended that she remove the implants to see if that would relieve the pain, and then if so, she would perform a mastopexy. Dr. Persons told Ms. Beauchemin that she would not, however, replace the implants, because then it would not be known if they were the cause of the pain. According to Dr. Persons, Ms. Beauchemin did not want the implants removed. Ms. Beauchemin did not return for any further visits with Dr. Persons. On September 29, 2021, Ms. Beauchemin had cosmetic surgery performed by Dr. Chris Gold at Kaiser. Ms. Beauchemin was offered MRI imaging preoperatively to help find the source of the pain. She declined and wished to move forward with surgery. According to Dr. Gold’s notes, the

4 indication for the surgery was “undesired cosmetic appearance,” and the planned procedures were breast implant exchange, breast capsulectomy, breast lift, mastopexy (all bilateral) and chest excision of a possible soft tissue mass (left). Dr. Gold believed Ms. Beauchemin’s breast implants were placed under the muscle because that is what she had told him, and no outside records were available for his review. Additional diagnoses from the past medical history included acute stress disorder and anxiety disorder. Dr. Gold stated in his notes that he removed the implants, which were intact.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

JENNIFER C. v. Los Angeles Unified School District
168 Cal. App. 4th 1320 (California Court of Appeal, 2008)
Jennings v. Palomar Pomerado Health Systems, Inc.
8 Cal. Rptr. 3d 363 (California Court of Appeal, 2003)
Hanson v. Grode
90 Cal. Rptr. 2d 396 (California Court of Appeal, 1999)
Aguilar v. Atlantic Richfield Co.
24 P.3d 493 (California Supreme Court, 2001)
Lattimore v. Dickey
239 Cal. App. 4th 959 (California Court of Appeal, 2015)
Garrett v. Howmedica Osteonics Corp.
214 Cal. App. 4th 173 (California Court of Appeal, 2013)
Prop. Cal. SCJLW One Corp. v. Leamy
236 Cal. Rptr. 3d 500 (California Court of Appeals, 5th District, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
Beauchemin v. Persons Plastic Surgery CA1/4, Counsel Stack Legal Research, https://law.counselstack.com/opinion/beauchemin-v-persons-plastic-surgery-ca14-calctapp-2025.